NO20040611L - Expandable gastric retention device. - Google Patents

Expandable gastric retention device.

Info

Publication number
NO20040611L
NO20040611L NO20040611A NO20040611A NO20040611L NO 20040611 L NO20040611 L NO 20040611L NO 20040611 A NO20040611 A NO 20040611A NO 20040611 A NO20040611 A NO 20040611A NO 20040611 L NO20040611 L NO 20040611L
Authority
NO
Norway
Prior art keywords
retention device
gastric retention
expandable gastric
materials
expandable
Prior art date
Application number
NO20040611A
Other languages
Norwegian (no)
Inventor
James W Ayres
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Publication of NO20040611L publication Critical patent/NO20040611L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives en gastrisk retensjonsanordning formet fra materialer som omfatter polymeriske materialer så som polysakkarider, og valgfritt ytterligere materialer inkluderende eksipienter, terepeutiske midler og diagnostiske midler, som forblir i magen i en regulerbar og forlenget tidsperiode.Described is a gastric retention device formed from materials comprising polymeric materials such as polysaccharides, and optionally additional materials including excipients, therapeutic agents and diagnostic agents, which remain in the stomach for an adjustable and extended period of time.

NO20040611A 2001-08-16 2004-02-11 Expandable gastric retention device. NO20040611L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31307801P 2001-08-16 2001-08-16
PCT/US2001/046146 WO2003015745A1 (en) 2001-08-16 2001-10-22 Expandable gastric retention device

Publications (1)

Publication Number Publication Date
NO20040611L true NO20040611L (en) 2004-04-16

Family

ID=23214285

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040611A NO20040611L (en) 2001-08-16 2004-02-11 Expandable gastric retention device.

Country Status (14)

Country Link
EP (1) EP1416914A1 (en)
JP (1) JP2005501097A (en)
KR (1) KR20040032918A (en)
CN (1) CN1543337A (en)
BR (1) BR0117123A (en)
CA (1) CA2456976A1 (en)
CO (1) CO5670360A2 (en)
IL (1) IL160363A0 (en)
MX (1) MXPA04001388A (en)
NO (1) NO20040611L (en)
NZ (1) NZ531461A (en)
PL (1) PL368327A1 (en)
WO (1) WO2003015745A1 (en)
ZA (1) ZA200402066B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040071143A (en) * 2001-11-21 2004-08-11 이-지-이엠, 인코포레이티드 Formulations for use in medical or diagnostic procedures
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp Enhanced absorption of modified release dosage forms
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7785291B2 (en) 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
CN101516408A (en) * 2006-07-19 2009-08-26 史密丝克莱恩比彻姆公司 Method for radiolabeling formulations for gamma scintigraphy assesment
CN102552103B (en) * 2010-12-20 2013-11-20 西安力邦医药科技有限责任公司 Lamivudine solid dispersion, and preparation method, pharmaceutical composition and use of the dispersion
EP2858604B1 (en) 2012-06-07 2024-02-21 Epitomee Medical Ltd Expanded device
CN105899198A (en) 2013-12-05 2016-08-24 图利普医疗有限公司 Retentive devices and systems for in-situ release of pharmaceutical active agents
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
RU2766335C2 (en) 2014-06-11 2022-03-15 Массачусетс Инститьют Оф Текнолоджи Retained structures and related methods
AU2016257711A1 (en) 2015-05-01 2017-10-26 Massachusetts Institute Of Technology Triggerable shape memory induction devices
EP3364946A4 (en) 2015-10-23 2019-06-26 Lyndra, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
EP4302817A3 (en) 2015-12-08 2024-02-21 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
JP2019532947A (en) 2016-09-30 2019-11-14 リンドラ，インコーポレイティド Gastric retention system for sustained delivery of adamantane drugs
AU2018279853B2 (en) 2017-06-09 2024-07-04 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
CN112004520A (en) * 2017-12-18 2020-11-27 特瑞斯制药公司 Modified release drug powder compositions comprising a gastric retentive raft forming system with triggered pulsed drug release
TR201914116A2 (en) * 2019-09-17 2021-04-21 Univ Yeditepe PRODUCTION METHOD OF NATURAL BIOMATERIALS AND CRYOGELS AND THE USE OF THESE CRYOGELS AS SOFT TISSUE SCACHE OR DRUG CARRIER SYSTEM
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
DE4406424A1 (en) * 1994-02-28 1995-08-31 Bayer Ag Expandable dosage forms
AU8699298A (en) * 1997-08-11 1999-03-01 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
CZ2001901A3 (en) * 1998-09-14 2001-08-15 Ranbaxy Laboratories Limited Pharmaceutical composition representing system of controlled delivery of a medicament for oral administration, providing time and local control
JP2000256216A (en) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd Gel composition
CA2412490A1 (en) * 2000-06-23 2002-01-03 Moshe Fleshner-Barak Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

Also Published As

Publication number Publication date
KR20040032918A (en) 2004-04-17
PL368327A1 (en) 2005-03-21
BR0117123A (en) 2004-09-28
ZA200402066B (en) 2005-05-09
IL160363A0 (en) 2004-07-25
CA2456976A1 (en) 2003-02-27
EP1416914A1 (en) 2004-05-12
CN1543337A (en) 2004-11-03
NZ531461A (en) 2008-03-28
JP2005501097A (en) 2005-01-13
CO5670360A2 (en) 2006-08-31
WO2003015745A1 (en) 2003-02-27
MXPA04001388A (en) 2004-05-27

Similar Documents

Publication Publication Date Title
NO20040611L (en) Expandable gastric retention device.
CY1116693T1 (en) A combination of azelastin and cycloneside
NO20053224D0 (en) Patient controlled drug administration device.
IS7076A (en) Single dose Mycoplasma hyopneumoniae vaccination and use of the drug for therapeutic use
DE60111908D1 (en) Implantable medical device
DE60123990D1 (en) MEDICAL APPARATUS
BR0110624B1 (en) annular fixation device.
DE60211896D1 (en) DEFORMABLE LONG-SIDED MEDICAL DEVICE
DE60133702D1 (en) Medical tripod device
DE60109904D1 (en) MEDICAL FEEDING DEVICE
NO20041516L (en) Training Device.
CY1108874T1 (en) USE OF IK-KINASE ANALYPES IN PAIN TREATMENT
NO20052855D0 (en) Phosphonoxycinazoline derivatives and their pharmaceutical use.
IS6806A (en) Compositions of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
NO20043702L (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
DE60307988D1 (en) MEDICAL DEVICE
NO20025580L (en) Medical device
ATE359034T1 (en) CONTROLLER LOOP STRUCTURE
DE60327090D1 (en) IMPLANTABLE MEDICAL DEVICE
ITTO20010005A1 (en) PHARMACEUTICAL FORMULATION.
DE60108524D1 (en) X-RAY SURGICAL DEVICE
ATE367178T1 (en) MEDICAL DEVICE
DE60327103D1 (en) PHARMACEUTICAL FORMS CONTAIN A PROTON PUMP, A NAZID AND A BUFFER
DK1498411T3 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
ITBO20000453A0 (en) EQUIPMENT AND PROCEDURE FOR THE STERILIZATION OF THE SOIL.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application